Image: Javier Zayas Photography /Getty Images About the Author Heidi Godman, Managing Director About the Reviewer Anthony L
While the FDA has approved its use in the treatment of reducing cardiovascular events and heart failure in some cases, preclinical studies have now branched out into chronic diseases/ disorders that are linked to insulin resistance
Retrospective Study In a retrospective study of more than 83,000 obese individuals, semaglutide was associated with a more than 50% lower incidence of alcohol use disorder (AUD) over a period of 12 months, regardless of age, gender, race, or diabetes status
And I dont believe this large number of patients in our program would lose that much weight with diet and exercise alone in such a short period of time
Benefits of GLP-1 Significant weight loss: Clinical trials have shown that GLP-1 can help people achieve significant weight loss, with an average of 15-20% of body weight lost over 68 weeks